Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale

Multiple Sclerosis

Volumn 11, Issue 1, 2005, Pages 81-84

  Ravnborg, M ^a,b   Blinkenberg, M ^a   Sellebjerg, F ^a   Ballegaard, M ^a   Larsen, S Helweg ^a   Sørensen, P Soelberg ^a  

^a Mental Health Services CPH   (Denmark)

^b NONE   (Denmark)

Author keywords

Assessment; EDSS; Impairment; Instruments; MSIS; Multiple sclerosis; Responsiveness; Validity

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; GENERAL CONDITION DETERIORATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPAIRMENT SCALE; NEUROLOGIC EXAMINATION; RATING SCALE; RELIABILITY; RETROSPECTIVE STUDY; VALIDATION PROCESS;

DISABILITY EVALUATION; EVALUATION STUDIES; HUMANS; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 13844320583     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1120oa     Document Type: Article

References (13)

1. Ravnborg M, Grønbech-Jensen M, Jønsson A. The MS-impairment scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis. Mult Scler 1997; 3: 31-42.
2. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
3. Amato MP, Fratiglioni L, Groppi C, Siracusa G, Amaducci L. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 1988; 45 746-48.
4. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC and the Canadian Cooperative MS Study Group. Interrater variability with Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990; 40: 971-75.
5. Kurtzke JF. Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 1970; 46: 493-512.
6. Dassel CH. Comparison of neurological and rehabilitation rating experiences in Holland. Acta Neurol Scand 1981; 64: 72-73.
7. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis. Neurology 1988; 38: 1793-98.
8. Lord FM, Novick MN. Statistical theories of mental test development. Reading, MA: Addison-Wesley, 1968.
9. Streiner DL, Norman GR. In Health measurement scales. a practical guide to their development and use, Oxford, New York: Oxford Medical Publications, 1989: 128-29.
10. Cutter GR, Baier ML, Rudick RA. Development of a multiple sclerosis functional composite (MSFC) as a clinical trial outcome measure. Brain 1999; 122: 871-82.
11. Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B et al. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology 2001; 56: 1324-30.
12. Kalkers NF, Groot de V. Multiple sclerosis functional composite (MSFC): relation to disease phenotype and disability strata. Neurology 2000; 54: 1233-39.
13. Cohen JA, Fischer JS, Cutter GR. Intrarater and interrater reliability of the multiple sclerosis functional composite (MSFC) outcome measure. Neurology 2000; 54: 802-806.